Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
Hong Kong · Delayed Price · Currency is HKD 2.435
-0.125 (-4.88%)
Sep 18, 2026, 4:08 PM HKT
HKG:6955 Market Cap
HKG:6955 has a market cap or net worth of 1.52 billion as of September 18, 2026. Its market cap has decreased by -82.97% in one year.
Market Cap
1.52B
Enterprise Value
1.21B
Revenue
720.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.44
ChartMarket Cap Chart
Since December 30, 2022, HKG:6955's market cap has decreased from 10.08B to 1.52B, a decrease of -84.97%. That is a compound annual growth rate of -39.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.52B | -71.49% |
| Dec 31, 2025 | 5.31B | 6.29% |
| Dec 31, 2024 | 5.00B | -36.66% |
| Dec 29, 2023 | 7.89B | -21.72% |
| Dec 30, 2022 | 10.08B | - |
| Dec 30, 2022 | 10.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.98B |
| HighTide Therapeutics | 1.89B |
| Guangzhou Innogen Pharmaceutical Group | 1.76B |
| Mabpharm | 1.61B |
| SinoMab BioScience | 1.56B |
| Beijing Biostar Pharmaceuticals | 1.49B |
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |